Cargando…
Regulation of cardiac miR-208a, an inducer of obesity, by Rapamycin and Nebivolol
OBJECTIVE: Resistance to obesity is observed in rodents and humans treated with Rapamycin (Rap) or Nebivolol (Neb). Since cardiac miR-208a promotes obesity, we tested whether the modes of actions of Rap and Neb involve inhibition of miR-208a. METHODS: Mouse cardiomyocyte HL-1 cells and Zucker obese...
Autores principales: | Gul, Rukhsana, Mahmood, Abuzar, Luck, Christian, Lum-Naihe, Kelly, Alfadda, Assim A, Speth, Robert C., Pulakat, Lakshmi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633375/ https://www.ncbi.nlm.nih.gov/pubmed/26381051 http://dx.doi.org/10.1002/oby.21227 |
Ejemplares similares
-
Inhibition of eNOS Partially Blunts the Beneficial Effects of Nebivolol on Angiotensin II-Induced Signaling in H9c2 Cardiomyoblasts
por: Gul, Rukhsana, et al.
Publicado: (2022) -
Differential Regulation of Cardiac Function and Intracardiac Cytokines by Rapamycin in Healthy and Diabetic Rats
por: Luck, Christian, et al.
Publicado: (2017) -
Comparison of the Protective Effects of Nebivolol and Metoprolol against LPS-Induced Injury in H9c2 Cardiomyoblasts
por: Gul, Rukhsana, et al.
Publicado: (2023) -
Regulation of Cardiac Expression of the Diabetic Marker MicroRNA miR-29
por: Arnold, Nicholas, et al.
Publicado: (2014) -
The β-blocker Nebivolol Is a GRK/β-arrestin Biased Agonist
por: Erickson, Catherine E., et al.
Publicado: (2013)